Empowered Funds LLC Has $1.11 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Empowered Funds LLC lifted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 89.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,871 shares of the biotechnology company’s stock after buying an additional 882 shares during the quarter. Empowered Funds LLC’s holdings in Axon Enterprise were worth $1,112,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of AXON. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC boosted its stake in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares during the period. Insigneo Advisory Services LLC increased its holdings in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares in the last quarter. Menard Financial Group LLC raised its stake in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares during the period. Finally, PFG Investments LLC lifted its holdings in shares of Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock valued at $5,631,561 over the last ninety days. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 2.8 %

AXON opened at $683.41 on Monday. The stock’s fifty day simple moving average is $623.22 and its 200 day simple moving average is $509.17. Axon Enterprise, Inc. has a 1-year low of $260.27 and a 1-year high of $698.67. The stock has a market cap of $52.11 billion, a PE ratio of 176.59, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. JMP Securities increased their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 4th. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Northland Securities raised their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Finally, Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.